NASDAQ:TRVN Trevena Earnings Date & Estimates $0.0005 0.00 (0.00%) As of 11/13/2026 03:42 PM Eastern Trevena is estimated to report earnings on Monday, November 16, 2026. Research:Profile Upcoming Earnings Announcement Announcement DateNovember 16, 2026 Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from TrevenaTrevena is expected to post earnings of -$50.00 per share on revenue of $782 thousand. Trevena has beaten the consensus EPS estimate in 5 of its last 7 quarters.Consensus EstimatesConsensus EPS-$50.00Expected Revenue$782 thousandRecent Track RecordLast ReportedQ3 2024Last Quarter EPS-$5.79Last Quarter Revenue$280 thousandEPS Beat Rate5 of last 7 quartersPrepare for the Earnings CallCompany ProfileQ3 2024 Earnings ReportAug 2024 Earnings ReportQ1 2024 Earnings Report Trevena Earnings FAQ When does Trevena report earnings? Trevena (NASDAQ:TRVN) is estimated to report earnings on Monday, November 16, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Trevena? Analysts expect Trevena to post earnings of -$50.00 per share for the quarter. How much revenue is Trevena expected to report? The consensus revenue estimate for Trevena is $782 thousand for the quarter. Trevena Earnings HeadlinesTrevena Inc.May 27, 2026 | marketwatch.comTrevena Restructures China Royalty Rights to Exit DebtJanuary 14, 2026 | tipranks.comYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year. The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%. A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold.November 16 at 1:00 AM | American Alternative (Ad)Softball: Conrad Weiser’s Alex Trevena earns statewide player of the year award; 5 other Berks players honoredJuly 8, 2025 | msn.comTrevena, Inc. (TRVN) - Yahoo FinanceJune 29, 2025 | finance.yahoo.comTrevena Enters Securities Exchange Agreement with InvestorMay 15, 2025 | tipranks.comSee More Trevena Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Trevena? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trevena and other key companies, straight to your email. Email Address About TrevenaTrevena (NASDAQ:TRVN) is a biopharmaceutical company focused on developing medicines for the treatment of acute and chronic pain, as well as disorders of the central nervous system. The company’s research has centered on G protein–coupled receptors and its “biased ligand” drug-discovery platform, which is intended to produce therapeutic effects while potentially reducing certain side effects associated with conventional treatments. Trevena’s principal commercial product is OLINVYK (oliceridine) injection, an opioid analgesic approved by the U.S. Food and Drug Administration in 2020 for the management of acute pain severe enough to require an intravenous opioid analgesic in adults. The product was developed for use in hospital and other medically supervised settings. Trevena has also investigated additional candidates, including oral and injectable therapies designed to address pain and central nervous system conditions. Founded in 2007 and headquartered in Chesterbrook, Pennsylvania, Trevena has historically operated primarily as a U.S.-based biotechnology company, with its lead product regulated and marketed in the United States. The company has undergone strategic and operational changes as it evaluated commercialization and development priorities. Its leadership has included biotechnology executive Carrie B. Jones, M.D., M.B.A., who served as president and chief executive officer during a period of the company’s commercial development.View Trevena ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/133 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCould Big Buybacks Be the Next Catalyst for These 3 AI Stocks?Cerebras Q3 Results: How Much More Proof Does Wall Street Need? Upcoming Earnings Walt Disney (11/17/2026)Home Depot (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.